Boaz Gur-Lavie Net Worth & Insider Trades
Boaz Gur-Lavie - Chief Financial Officer, Pluristem Therapeutics Inc
What is Boaz Gur-Lavie's Net Worth?
The current estimated net worth of Pluristem Therapeutics Inc's Chief Financial Officer, Boaz Gur-Lavie, is estimated to be about $145.21K . Boaz Gur-Lavie owns about 59,228 units of Pluristem Therapeutics Inc common stock. In the last year at Pluristem Therapeutics Inc, Boaz Gur-Lavie has sold an estimated value of $0 worth.
What is Boaz Gur-Lavie's Past Insider Trading?
Boaz Gur-Lavie's largest purchase order was 3,478 units , worth over $9.88K on September 16, 2014. In total, Boaz Gur-Lavie has made about 4 transactions over a year of their time at Pluristem Therapeutics Inc. Boaz Gur-Lavie usually trades in September, with the busiest year in 2014. The most recent transaction was a purchase order of 1,250 units , worth over $3.44K on September 17, 2014.
Boaz Gur-Lavie
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Boaz Gur-Lavie's' Mailing Address?
- Mailing address is Matam Advanced Technology Park Building No. 5 Haifa L3 31905 Israel
Pluristem Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|
| Zami Aberman | 2020 | $439,704 | - | $61,540 | $501,244 |
| Zami Aberman | 2019 | $551,137 | $478,500 | $66,857 | $1,096,494 |
| Yaky Yanay | 2020 | $320,911 | - | $29,466 | $350,377 |
| Yaky Yanay | 2019 | $396,632 | $461,100 | $29,253 | $886,985 |
| Chen Franco-Yehuda | 2020 | $179,229 | - | $28,461 | $207,690 |
| Chen Franco-Yehuda | 2019 | $78,889 | $112,329 | $13,599 | $204,817 |
| No matching records found | |||||
Source: https://www.sec.gov/Archives/edgar/data/1158780/000121390021020786/ea139144-def14a_pluristem.htm
What are Pluristem Therapeutics Inc's Past Insider Trades?
Pluristem Therapeutics Inc's most recent insider trade came on February 14, 2022 by Zami Aberman who bought 80,616 units worth $145.11K . In the last 14 years, insiders at Pluristem Therapeutics Inc have sold an estimated value of $7.29M and bought an estimated value of $14.34M worth of shares. Insider trading is most common in December, with the busiest year in 2009. The most active traders at the company are Zami Aberman, Director, Yaky Yanay, CEO & President, and Israel Ben-Yoram, Director .
PAM TRANSPORTATION SERVICES INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||